INVEST +
We are excited to partner with Chair Capital as our Valuation Anchor and next round investor.
Invest in Skin Scanner, a first-prize winner
Our first-of-its-kind scanner is an innovative imaging system to detect skin and lesion deformities worldwide. For cancer, cosmetics
and more.
Patented Technology
@ 2026
The Problem
Currently, Skin cancer detection that relies on Color change, which happens at a late stage, leads to a high mortality rate.
Our Solution
An innovative handheld scanner to detect deformities under the skin at an EARLY stage.
skin cancer.
We are excited to partner with Chair Capital as our Valuation Anchor. This formal engagement provides Patternox with a contracted lead for our next round, alongside a commitment to settle interim bridge funding and loan notes at cost. This move de-risks our growth trajectory and ensures we scale with a focus on preserving founder equity and investor value
The need: About 1.9 billion people with skin deformities.
First Markets:
-
Particularly primary care physicians (PCPs) / General practitioners (GPs)
-
Integrated delivery networks (IDNs)
Second Markets:
-
Dermatology Clinics
-
Beauticians / Laser Removal practitioners
The biggest Markets:
-
Home Users worldwide.
